Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models

BACKGROUND: Sorafenib is effective in treating hepatoma, but most patients develop resistance to it. STAT3 signaling has been implicated in sorafenib resistance. Artesunate (ART) and 20(R)-ginsenoside Rg3 (Rg3) have anti-hepatoma effects and can inhibit STAT3 signaling in cancer cells. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying-Jie, Wu, Jia-Ying, Deng, Yu-Yi, Wu, Ying, Wang, Xiao-Qi, Li, Amy Sze-man, Wong, Lut Yi, Fu, Xiu-Qiong, Yu, Zhi-Ling, Liang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120623/
https://www.ncbi.nlm.nih.gov/pubmed/35600776
http://dx.doi.org/10.1016/j.jgr.2021.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120623/
https://www.ncbi.nlm.nih.gov/pubmed/35600776
http://dx.doi.org/10.1016/j.jgr.2021.07.002

Ejemplares similares